MOYES JAY M 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jun 17, 2025
Insider Transaction Report
Form 4
MOYES JAY M
Director
Transactions
- Sale
Common Stock
2025-06-13$3.40/sh−22,000$74,800→ 53,322 total
Footnotes (2)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 03/12/2025
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.